Non-activated prothrombin complex concentrates for major bleeding in patients on apixaban and rivaroxaban
Published
Saved in:
| Main Author: | Sheikh-Taha, Marwan (author) |
|---|---|
| Format: | article |
| Published: |
2019
|
| Online Access: | http://hdl.handle.net/10725/11607 https://doi.org/10.1007/s11739-019-02218w http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://link.springer.com/article/10.1007/s11739-019-02218-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of apixaban- and rivaroxaban-associated major bleeding using 4-factor prothrombin complex concentrate
by: Sheikh-Taha, Marwan
Published: (2019) -
Febrile Neutropenia and Hemorrhagic Stroke in a Thalassemia Major Patient
by: Sheikh-Taha, Marwan
Published: (2007) -
Use of acid suppressive therapy in hospitalized non-critically ill patients
by: Sheikh-Taha, Marwan
Published: (2012) -
Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data
by: Majdoleen Alalawneh (13961580)
Published: (2023) -
Assessment of bleeding in chronic liver disease and coagulopathy using the IMPROVE bleeding criteria
by: Chamoun, Nibal
Published: (2019)